Vouliez-vous dire

Résultats de la recherche - 2 results

Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.

content is determined for batch release of a human papilloma virus vaccine and a hepatitis B vaccine. Testing by OMCL 's on other adjuvants for other vaccines can be performed for information only. ...

Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

Vaccines, DNA Abstract: OBJECTIVE: To determine the efficacy of Ag85A- DNA against challenge with a highly virulent human clinical isolate of Mycobacterium tuberculosis (CSU37) and to compare the potencies of ...

QR code

QR code for this page URL